Vitamin B6 Therapy Does Not Improve Hematocrit in Hemodialysis Patients Supplemented with Iron and Erythropoietin

Publisher： Karger

E-ISSN： 2235-3186|87|4|328-332

ISSN： 1660-8151

Source： Nephron, Vol.87, Iss.4, 2001-03, pp. : 328-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of the Impact of a New Synthetic Vitamin E-Bonded Membrane on the Hypo-Responsiveness to the Erythropoietin Therapy in Hemodialysis Patients: A Multicenter Study

By  

Blood Purification, Vol. 43, Iss. 4, 2017-03 ,pp. : 338-345

Karger

Access to resources Recommend Favorite

Hepatitis G and Erythropoietin Therapy in Patients Undergoing Hemodialysis

By  

Nephron, Vol. 79, Iss. 4, 1998-07 ,pp. : 507-507

Karger

Access to resources Recommend Favorite

Effect of Weekly or Successive Iron Supplementation on Erythropoietin Doses in Patients Receiving Hemodialysis

By  

Nephron, Vol. 89, Iss. 1, 2001-08 ,pp. : 110-112

Karger

Access to resources Recommend Favorite

Intravenous Low-Dose Iron Administration in Hemodialysis Patients Treated with Erythropoietin

By  

Nephron, Vol. 80, Iss. 3, 1998-11 ,pp. : 369-370

Karger

Access to resources Recommend Favorite

No Effect of Losartan on Response to Erythropoietin Therapy in Patients Undergoing Hemodialysis

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 538-539

Karger

Access to resources Recommend Favorite